Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

5 Pharma Stocks to Buy as Patents Expire
TheStreet.com
Friday, July 29, 2011 - 9:46am
tags:
patents, Merck, Pfizer, Bristol-Myers Squibb, JNJ, Eli Lilly
Yervoy hits the market with $95M bang
Fierce Pharma
Friday, July 29, 2011 - 9:44am
tags:
Yervoy, Bristol-Myers Squibb, melanoma
5 High Yielding Birth Control Stocks
Seeking Alpha
Friday, July 29, 2011 - 9:40am
tags:
birth control, Merck, Pfizer, Teva Pharmaceuticals, JNJ
AstraZeneca Settles Most Seroquel Suits
NY Times, NY
Friday, July 29, 2011 - 9:21am
tags:
Seroquel, AstraZeneca, lawsuits, antipsychotics
Merck to Cut 12% of Workforce, Deepen Savings
Bloomberg
Friday, July 29, 2011 - 9:19am
tags:
layoffs, restructuring, Merck
Amgen 2nd-qtr profit falls; revenue rises 4 pct
Reuters
Friday, July 29, 2011 - 8:30am
tags:
Amgen, earnings
[video] The Next Big Thing In Biotech: Spectrum
TheStreet.com
Friday, July 29, 2011 - 8:28am
tags:
Spectrum Pharmaceuticals, earnings
Oncothyreon: Analyzing Trial Data and Concluding Likely Success
Seeking Alpha
Friday, July 29, 2011 - 8:26am
tags:
Oncothyreon, Stimuvax, vaccines, cancer
Merck plans more job cuts; 2Q profit rises
Yahoo/AP
Friday, July 29, 2011 - 8:22am
tags:
Merck, earnings, layoffs
Kindler Undone: The Dysfunctional Pfizer Culture
Pharmalot
Thursday, July 28, 2011 - 11:40pm
tags:
Pfizer, corporate culture, Jeff Kindler
Pozen takes 2nd-quarter loss as payments related to new arthritis drug Vimovo decline
Yahoo/AP
Thursday, July 28, 2011 - 11:38pm
tags:
arthritis, vivmo, earnings, Pozen
Why Medicis Pharmaceutical May Be About to Take Off
Motley Fool
Thursday, July 28, 2011 - 11:37pm
tags:
Medicis
Medicis Pharmaceutical Earnings Preview
Motley Fool
Thursday, July 28, 2011 - 7:58pm
tags:
earnings, Medicis
Pfizer’s Prempro Didn’t Cause Woman’s Cancer, Jury Concludes
Bloomberg
Thursday, July 28, 2011 - 7:56pm
tags:
Pfizer, Prempro, Wyeth
Pfizer Offer for Remaining Shares Not Enough, Icagen Holders Say
Bloomberg
Thursday, July 28, 2011 - 7:56pm
tags:
Icagen, Pfizer, M&A
Pfizer: Dividend Dynamo or Blowup?
Motley Fool
Thursday, July 28, 2011 - 6:10pm
tags:
dividends, Pfizer
Bristol-Myers Squibb: New Product Potential Outstanding, But Patent Cliff Looms
Seeking Alpha
Thursday, July 28, 2011 - 6:08pm
tags:
pipelines, earnings, Bristol-Myers Squibb, patents
Pfizer Is Said to Prepare for $10.5 Billion Sale of Infant-Nutrition Unit Q
Bloomberg
Thursday, July 28, 2011 - 6:07pm
tags:
Pfizer, infant formula, Nestle, Abbott Laboratories, Danone SA, M&A
Vertex Earnings: $75M in Incivek Sales
TheStreet.com
Thursday, July 28, 2011 - 6:05pm
tags:
earnings, Vertex Pharmaceuticals
United Therapeutics net income nearly doubles
Bizjournals.com
Thursday, July 28, 2011 - 2:02pm
tags:
earnings, United Therapeutics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.